New Sanofi boss seen well-placed to lead $13 bln asset selloff

PARIS, Nov 6 (Reuters) - Sanofi could hope to get over 12 billion euros ($13 billion) should it decide to sell its Merial animal health unit and its European generics business, and the French drugmaker's new boss is seen as well-placed to find a buyer.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.